Workflow of the complete strategy for the identification of novel immunogenic peptides. (A) Bioinformatic workflow for the in silico prediction of HCMV-derived peptides. (B) Workflow of the in vitro validation strategy of the in silico HCMV-derived peptide predictions. BreA, Brefeldin A; ICS, intracellular cytokine staining;